Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 113 - 120 of 11616 results
OMB Issues Additional Guidance to Federal Agencies on their Acquisition of AI — AI: The Washington Report
October 24, 2024| Article| Viewpoint
AI: The New Legal Powerhouse — Why Lawyers Should Befriend the Machine to Stay Ahead
October 24, 2024| News
California Privacy Protection Agency Reminds Us that “Dark Patterns” Are Illegal
October 22, 2024| Blog| Viewpoint
Biotech Cos. Keep Dancing Despite Purple Book Disclosures
October 22, 2024| News
The New Rubric for Obviousness-Type Double Patenting
October 21, 2024| News
Video Camera Patent Ruling Shows Proving Novelty Is Essential
October 21, 2024| News
Healthcare’s AI Deal Advantage
October 21, 2024| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.